mRNA

News

RFK Jr cancels $500m in funding for mRNA vaccines

RFK Jr is cutting $500m in funding for mRNA vaccines for diseases like flu and COVID-19, but critics say his reasons for doing so are spurious.

News

Moderna shines spotlight on new flu vaccine data

Moderna may be facing regulatory uncertainty in the US for its vaccine pipeline, but at least its clinical data is hitting the right notes.

Oncology

ASCO 2025 interview with Annemarie Hanekamp

BioNTech’s ASCO 2025 oncology advances: New data on bispecif...

At ASCO 2025, BioNTech presented 7 abstracts on four selected pipeline candidates in mesothelioma, lung cancer, prostate cancer, and melanoma.

News

Has mRNA delivered a breakthrough in quest for HIV cure?

A new way to deliver mRNA to T cells could allow HIV that is hiding away to be exposed and targeted with antiretroviral therapies, say scientists.

R&D

Partner Content

Europe’s Largest Industry-Led & Dedicated Gathering for mRNA...

The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to showcasing the hottest disease targets,

R&D

4th mRNA Analytical Development & Quality Control Summit banner

Partner Content

4th mRNA Analytical Development & Quality Control Summit | F...

Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.

RFK Jr cancels $500m in funding for mRNA vaccines

Moderna shines spotlight on new flu vaccine data

BioNTech’s ASCO 2025 oncology advances: New data on bispecif...

Has mRNA delivered a breakthrough in quest for HIV cure?

Europe’s Largest Industry-Led & Dedicated Gathering for mRNA...

4th mRNA Analytical Development & Quality Control Summit | F...

NHS risks missing out on independent prescriber benefits

Using AI-driven synthetic personas to take your insights fur...

mRNA

Editor's Picks